How Corporations Really Know What’s Good for the Patient

Posted by Richard Goodfellow on July 26th, 2017

Richard Goodfellow of CEO of biotech Scancell Talks about how patient advocacy groups are central to understanding patient needs. He emphasizes that working with advocacy groups are an innovative and productive way of ensuring patients are at the forefront of everything they do.

Click here to read the full commentary

Comments are closed.